1st AndroGel Trial: Plaintiffs Allowed to Present All Claims
1st AndroGel Trial: Plaintiffs Allowed to Present All Claims
Introduction
Retrial for a previously tossed $150 million AndroGel verdict announced as punitive damages and no compensatory damages in favor of the plaintiff began on March 7. The plaintiff was allowed to present all claims to the jury by the U.S. District Judge Matthew Kennelly presiding over the centralized testosterone replacement therapy lawsuits in the Northern District of Illinois. The plaintiff was earlier ordered by the court that the jury would only reconsider the issue of fraudulent misrepresentation. The court vacated the prior judgment in its entirety and ordered a new trial on all claims.
Other defendants named in the testosterone litigation namely Eli Lilly, Auxilium Pharmaceuticals, Endo Pharmaceuticals, and GlaxoSmithKline have opted to settle the lawsuits against them. However, no signs of settlements are seen from AbbVie and the company faces nearly 4,510 cases nationally over injuries blamed on AndroGel.
Comments
Latest News
Oregon to Get $66M in Sackler Opioid Settlement
Categories: Opioids
Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…
Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors
Categories: E-Cigarette: JUUL
As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.
A study published in Environmental Health Perspectives in…
Appeals Court Upholds $611M Roundup Verdict
Categories: Roundup
A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.
The case involved three plaintiffs from New…